- Activation of Prodrugs by Carboxylesterase (SJ-98-0001)
- Alternate mTOR Pathway (SJ-09-0021)
- ARF and HDM2 interaction domains (SJ-01-0016)
- Assay for ATM Kinase Modulation (SJ-02-0008)
- BMP Compounds for treating diseases caused by defective or diminished BMP signaling (Medulloblastoma) - (SJ-15-0008)
- Caspase 1 inhibition to overcome glucocorticoid resistance (SJ-13-0039)
- CD7 CAR placed in CD7neg memory cells (SJ-15-0020)
- Cells That Lack p19Ink4d and p27Kip1 Activity/p19Ink4d and p27Kip1 Null Mice (SJ-98-0023)
- Chimeric gene and protein that can be used to create Optogranules: Light induced stress granules (SJ-18-0010)
- DCN1 Inhibitors (SJ-16-0002)
- Defects in LC3-associated phagocytosis (LAP) associated with Lupus (SJ-16-0025)
- Discovery of a fluorescent vinblastine analog with high affinity to the human pregnane X receptor (hPXR) Ligand (SJ-13-0009)
- Discovery of a novel inhibitor of constitutive androstane receptor (CAR) that does not activate pregnane X receptor (PXR) (SJ-14-0039)
- DON and small molecule Bcl-2 family antagonists treating glutamine addicted cell lines for Neuroblastomas and Ewing sarcomas (SJ-13-0026)
- Hematopoietic progenitor cell lines with myeloid and lymphoid potential (SJ-11-0003)
- Identification of Toll-like receptor signaling inhibitors (SJ-18-0008)
- Improving HSC Engraftment by Inhibiting GASP Genes (SJ-16-0029)
- Interaction of Reelin With Very Low Density Lipoprotein (VLDL) Receptor (SJ-98-0045)
- Method for Enhancing Recombinant Antibody Production (SJ-08-0032)
- Methods and compositions for the prevention and treatment of hearing loss using CDK2 inhibitors (SJ-14-0028)
- Methods for Diagnosing and Treating Learning or Mental Disorders with the SERCA2 Protein and miRNAs that regulate SERCA2 Levels (SJ-10-0003 and SJ-12-0020)
- Ozz, A Protein That Regulates Development and Function of Muscle Cells (SJ-99-0010)
- Rapid Cloning of T Cell Receptors (SJ-16-0001)
- Regulating p53 Translation and Function (SJ-05-0002)
- Respiratory Cell Isolation and Propagation for Pathogen Study (SJ-18-0028)
- SCCRO Peptide Inhibitor (SJ-11-0014)
- Use of specific retinoid receptor agonists and antagonists as cancer therapies (SJ-14-0011)